Pharmacokinetic study of the interaction between rifabutin and delavirdine mesylate in HIV-1 infected patients (Q73513977)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9224961%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

title

Pharmacokinetic study of the interaction between rifabutin and delavirdine mesylate in HIV-1 infected patients (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9224961%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

1 reference

1 reference

M T Borin

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9224961%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

J H Chambers

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9224961%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

B J Carel

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9224961%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

W W Freimuth

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9224961%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

S Aksentijevich

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9224961%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

A A Piergies

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9224961%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

publication date

1 June 1997

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9224961%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9224961%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

volume

35

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9224961%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9224961%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

page(s)

53-63

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9224961%20AND%20SRC:MED&resulttype=core&format=json

Pharmacokinetic study of the interaction between rifampin and delavirdine mesylate

4 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2897%2900011-9

7 January 2021

Rifabutin. A review of its antimicrobial activity, pharmacokinetic properties and therapeutic efficacy

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2897%2900011-9

7 January 2021

Steady-state pharmacokinetics of delavirdine in HIV-positive patients: effect on erythromycin breath test

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2897%2900011-9

7 January 2021

Bisheteroarylpiperazine reverse transcriptase inhibitor in combination with 3'-azido-3'-deoxythymidine or 2',3'-dideoxycytidine synergistically inhibits human immunodeficiency virus type 1 replication in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2897%2900011-9

7 January 2021

LM 427,a new spiropiperidylrifamycin: In vitro and in vivo studies

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2897%2900011-9

7 January 2021

U-90152, a potent inhibitor of human immunodeficiency virus type 1 replication

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2897%2900011-9

7 January 2021

The increase in urinary excretion of 6 beta-hydroxycortisol as a marker of human hepatic cytochrome P450IIIA induction

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2897%2900011-9

7 January 2021

Pharmacokinetic drug interactions with antimicrobial agents

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2897%2900011-9

7 January 2021

Tolerance and pharmacokinetic interactions of rifabutin and clarithromycin in human immunodeficiency virus-infected volunteers.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2897%2900011-9

7 January 2021

Determination of rifabutin in human plasma by high-performance liquid chromatography with ultraviolet detection

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2897%2900011-9

7 January 2021

Comparative effects of rifabutin and rifampicin on hepatic microsomal enzyme activity in normal subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2897%2900011-9

7 January 2021

Nonnucleoside reverse transcriptase inhibitors that potently and specifically block human immunodeficiency virus type 1 replication

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2897%2900011-9

7 January 2021

Pharmacokinetics of rifabutin

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2897%2900011-9

7 January 2021

Simple, rapid and sensitive high-performance liquid chromatographic determination of delavirdine and its N-desisopropyl metabolite in human plasma

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2897%2900011-9

7 January 2021

Autoinduction of rifabutin metabolism in man.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2897%2900011-9

7 January 2021

Reduced serum levels of clarithromycin in patients treated with multidrug regimens including rifampin or rifabutin for Mycobacterium avium-M. intracellulare infection

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2897%2900011-9

7 January 2021

Application of Akaike's information criterion (AIC) in the evaluation of linear pharmacokinetic equations.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2897%2900011-9

7 January 2021

10.1016/S0166-3542(97)00011-9

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9224961%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

1 reference